Abiopharma

🔍 Fargis Edward C (Executive)

Company: Privia Health Group, Inc. (PRVA)

Report Date: 2026-03-10

Detailed Transactions and Holdings:

• Acquired 28,268 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-03-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 111,979.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.